Aspergillus sensitisation: an underappreciated treatable trait in airway disease

Eur Respir J. 2023 Jan 6;61(1):2202042. doi: 10.1183/13993003.02042-2022. Print 2023 Jan.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Allergens
  • Aspergillus
  • Aspergillus fumigatus / immunology
  • Asthma* / drug therapy
  • Humans
  • Pulmonary Disease, Chronic Obstructive*
  • Respiration Disorders*

Substances

  • Allergens